Results 191 to 200 of about 2,589,815 (356)

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Circulation Research, 1986
M. Bristow, R. Ginsburg, V. Umans, M. Fowler, W. Minobe, R. Rasmussen, P. Zera, R. Menlove, P. Shah, S. Jamieson   +9 more
semanticscholar   +1 more source

Phenotyping Overactive Bladder—Part 1: Are There Different Types of Urgency and Can They be Translated to Clinical, Urodynamic and Radiological Phenotyping? ICI‐RS 2025

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Overactive bladder (OAB) is defined as urinary urgency, usually accompanied by increased daytime frequency and/or nocturia, with urgency urinary incontinence (OAB‐wet) or without (OAB‐dry), in the absence of urinary tract infection or other detectable disease.
John E. Speich, D. Carolina Ochoa, Pradeep Tyagi, Apostolos Apostolidis, Sanjay Sinha, Claire Hentzen, Marcus Drake, Paul Abrams, Alan J. Wein, Michel Wyndaele   +9 more
wiley   +1 more source

GDF15: Anxiety Signalling From the Adipose Tissue

iNew Medicine, EarlyView.
Song‐Yang Zhang
wiley   +1 more source

Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial

Neurourology and Urodynamics, EarlyView.
ABSTRACT Purpose Vibegron was associated with improvements in efficacy versus placebo and was well tolerated in men with overactive bladder (OAB) on pharmacotherapy for benign prostatic hyperplasia (BPH) in the COURAGE trial (NCT03902080). Additional safety, bladder function, and urodynamics data are provided.
Eric S. Rovner, Janet Owens‐Grillo, Elizabeth Thomas, Sender Herschorn, Kenneth M. Peters, David Staskin, Salim Mujais   +6 more
wiley   +1 more source

The beta1-adrenergic receptor in the heart. [PDF]

Cell Death Discov
Xu W, Li J, Ju J, Liu M, Wang W, Cheng M, Zhang X, Cui X, Chen H.   +8 more
europepmc   +1 more source

Abnormal Norepinephrine Clearance and Adrenergic Receptor Sensitivity in Idiopathic Orthostatic Intolerance [PDF]

, 1999
Giris Jacob, J. R. Shannon, Fernando Costa, Raffaello Furlan, Italo Biaggioni, Rogelio Mosqueda‐Garcia, Rose Marie Robertson, David L. Robertson   +7 more
openalex   +1 more source

A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor.

Journal of Biological Chemistry, 1980
A. De Lean, J. Stadel, Robert J Lefkowitzl   +2 more
semanticscholar   +1 more source

Addition of Phentermine‐Topiramate to a Digitally Enhanced Lifestyle Intervention: A Double‐Blind Randomized Clinical Trial

Obesity, EarlyView.
ABSTRACT Objective This study compared the effects of phentermine‐topiramate‐ER (mid‐dose 7.5/46 mg) versus placebo on weight loss and cardiovascular disease (CVD) risk outcomes when used as an adjunct to a digitally enhanced lifestyle intervention (DELI).
Alejandro Campos, Wissam Ghusn, Lizeth Cifuentes, Daniel Sacoto, Sima Fansa, Diego Anazco, Maria L. Ricardo‐Silgado, Anas Hashem, Megan Schaefer, William S. Harmsen, Heather J. Gunn, Craig Peterson, Deborah Larsen, Santosh T. Varghese, Maria D. Hurtado, Andres Acosta   +15 more
wiley   +1 more source

Phosphorylation of Ca _v 1.2 on S1928 uncouples the L‐type Ca ²⁺ channel from the β ₂ adrenergic receptor [PDF]

, 2016
Tommaso Patriarchi, Hai Qian, Valentina Di Biase, Zulfiquar A Malik, Dhrubajyoti Chowdhury, Jennifer L. Price, Erik A Hammes, Olivia R. Buonarati, Ruth E. Westenbroek, William A. Catterall, Franz Hofmann, Yang K. Xiang, Geoffrey G. Murphy, Chao‐Ye Chen, Manuel F. Navedo, Johannes Hell   +15 more
openalex   +1 more source

Structure of a β1-adrenergic G-protein-coupled receptor

Nature, 2008
Tony Warne, M. Serrano-Vega, J. Baker, R. Moukhametzianov, P. Edwards, R. Henderson, A. Leslie, C. Tate, G. Schertler   +8 more
semanticscholar   +1 more source